SALT LAKE CITY, July 2, 2012 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications, today announced the appointment of Sherree Frazier as Vice President of Sales and Marketing. Ms. Frazier will lead the commercial activities of the organization, including the development and launch of ProNid™, Sera's novel diagnostic test to predict preterm birth risk.
